Is glucose-6-phosphate dehydrogenase deficiency associated with COVID-19 infection, severity, and death? A cohort study from the Brazilian Amazon
PLOS One · 2025
DOI: 10.1371/journal.pone.0331729 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift PLOS One, 2025. Verfasst von Adila L B Dias und 13 weiteren Autor:innen. Beteiligte Einrichtung: Fundação de Medicina Tropical Dr Heitor Vieira Dourado, Manaus, Brazil. Hauptthemen laut MEDLINE: COVID-19, Glucosephosphate Dehydrogenase Deficiency. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Fundação de Amparo à Pesquisa do Estado do Amazonas, Conselho Nacional de Desenvolvimento Científico e Tecnológico.
Abstract (Originalsprache)
Background
Glucose-6-phosphate dehydrogenase deficiency (G6PDd) is a common genetic disorder that impairs the cellular antioxidant response and has been hypothesized as a potential risk factor for severe outcomes in viral infections, including COVID-19. However, clinical evidence remains limited, especially in regions with high G6PDd prevalence.
Methods
We conducted a retrospective cohort study using secondary data from four health information systems from health facilities in the Brazilian Amazon (E-SUS Notifica, SIVEP-Gripe, SIM, and a G6PD enzyme activity database). The study population consisted of 3,955 male participants, including 206 with confirmed G6PDd. We used logistic regression to assess associations between G6PDd and COVID-19 infection, hospitalization, and death. Cox proportional hazards models and Kaplan-Meier curves were applied to evaluate time-to-event outcomes.
Results
No statistically significant association was found between G6PDd and SARS-CoV-2 infection (OR = 1.15; 95% CI: 0.70–1.79; p = 0.6), hospitalization (OR = 1.13; 95% CI: 0.27–3.20; p = 0.8), or death (OR = 0.00; p > 0.9). Age was a significant risk factor for all outcomes, and individuals identified as Asian had a higher likelihood of infection (OR = 2.87; 95% CI: 1.57–5.29; p < 0.001).
Conclusion
In this cohort from the Brazilian Amazon, G6PD deficiency was not associated with an increased risk of COVID-19 infection or severe outcomes. These findings emphasize the importance of considering ethnic and genetic diversity in epidemiological analyses and health policy planning, particularly in regions with high G6PDd prevalence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Fundação de Medicina Tropical Dr Heitor Vieira Dourado, Manaus, Brazil.
- Escola Superior de Ciências da Saúde, Universidade do Estado do Amazonas, Manaus, Brazil.
- Instituto de Pesquisas Leônidas & Maria Deane, Fundação Oswaldo Cruz, Manaus, Brazil.
- Faculdade de Ciências Farmacêuticas, Universidade Federal do Amazonas, Manaus, Brazil.
- Università degli Studi di Siena, Siena, Italy.
- Universidade Nilton Lins, Manaus, Brazil.
ORCID-Profile: Marco Aurelio Sartim, Gabriel Dos Santos Mouta, Fernando Almeida-Val, Vanderson de Souza Sampaio, Wuelton Monteiro
Förderung
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Fundação de Amparo à Pesquisa do Estado do Amazonas
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
Zitieren
APA
Dias, A. L. B., Nascimento, J. R., Brito-Sousa, J. D., Sartim, M. A., da Silva, K. F., Silva-Neto, A. V., Dos Santos Mouta, G., da Silva Balieiro, P. C., Baia-da-Silva, D. C., Almeida-Val, F., de Melo, G. C., Sampaio, V. S., Lacerda, M., & Monteiro, W. (2025). Is glucose-6-phosphate dehydrogenase deficiency associated with COVID-19 infection, severity, and death? A cohort study from the Brazilian Amazon. PLOS One. https://doi.org/10.1371/journal.pone.0331729
Vancouver
Dias ALB, Nascimento JR, Brito-Sousa JD, Sartim MA, da Silva KF, Silva-Neto AV, et al. Is glucose-6-phosphate dehydrogenase deficiency associated with COVID-19 infection, severity, and death? A cohort study from the Brazilian Amazon. PLOS One. 2025. doi:10.1371/journal.pone.0331729
BibTeX
@article{Dias2025,
author = {Dias, Adila L B and Nascimento, Joabi Rocha and Brito-Sousa, José Diego and Sartim, Marco Aurelio and da Silva, Kamilla Freitas and Silva-Neto, Alexandre Vilhena and Dos Santos Mouta, Gabriel and da Silva Balieiro, Patricia Carvalho and Baia-da-Silva, Djane Clarys and Almeida-Val, Fernando and de Melo, Gisely Cardoso and Sampaio, Vanderson de Souza and Lacerda, Marcus and Monteiro, Wuelton},
title = {Is glucose-6-phosphate dehydrogenase deficiency associated with COVID-19 infection, severity, and death? A cohort study from the Brazilian Amazon},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0331729}
}
EUVIMED